HLST 1010 Chapter Notes - Chapter 15: Precautionary Principle, Health Canada, Pharmaceutical Industry
11 Dec 2014
School
Department
Course
Professor
Document Summary
Chapter 15 pharmaceutical policy high degree of concentration of power in one agency but low degree of. Clientele pluralism autonomy while in private sectors organizations has a lot of resources and can act on behalf if its members. Cost recovery market and fee for evaluation of new drug submission helps pay operating costs of. Generic competition identical but at lower costs usually produced by canadian companies new innovation of company is protected from competition for 20 years. Patent protection process of discovering a new drug and doing the necessary. Research and development testing to bring it to market annual fee paid to therapeutic products programme for each drug they generic drug companies compete with brand name drugs that are. Price of medication has been increasing by more than 10 each year. Regulation of drug safety quality and efficacy is responsibility of. State doesn t have means to carry out testing and trials for drugs.
